Sustained release triple drug loaded colloidosomes for management of Parkinson's disease

被引：0
|
作者：
Bhargava, Saurabh [1 ]
Bhargava, Vishal [2 ]
机构：
[1] Signa Coll Pharm, Pharm, Kanpur, Uttar Pradesh, India
[2] GTB Hosp, R&d, Kanpur, Uttar Pradesh, India
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2021年 / 429卷
关键词：
D O I：
10.1016/j.jns.2021.119591
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
119591
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [1] Sustained release triple drug loaded colloidosomes for management of Parkinson's disease
    Bhargava, Saurabh
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 90 - 91
  • [2] SUSTAINED RELEASE TRIPLE DRUG LOADED COLLOIDOSOMES FOR MANAGEMENT OF PARKINSON'S DISEASE
    Bhargava, S.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 46 - 46
  • [3] Sustained release triple drug loaded colloidosomes for management of Parkinson's disease
    Bhargava, M.
    Bhargava, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [4] PARKINSONISM AND RELATED DISORDERS 122 (2024) 106846 SUSTAINED RELEASE TRIPLE DRUG LOADED COLLOIDOSOMES FOR MANAGEMENT OF PARKINSON'S DISEASE
    Bhargava, S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [5] Sustained release triple drug loaded Microbaloons for management of Parkinson's Disease
    Bhargava, S.
    MOVEMENT DISORDERS, 2019, 34
  • [6] Multi-Drug-Loaded Microcapsules with Controlled Release for Management of Parkinson's Disease
    Baek, Jong-Suep
    Choo, Chee Chong
    Qian, Cheng
    Tan, Nguan Soon
    Shen, Zexiang
    Loo, Say Chye Joachim
    SMALL, 2016, 12 (27) : 3712 - 3722
  • [7] Drug management of Parkinson's disease
    Kishore, A
    Snow, BJ
    CANADIAN FAMILY PHYSICIAN, 1996, 42 : 946 - &
  • [8] Sustained release of drug loaded nanofibers for wound dressing applications
    Singh, Manvi
    Chauhan, Deepika
    Gill, Renu
    Iqbal, Zeenat
    Solanki, Partima
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2022, 59 (04): : 479 - 485
  • [9] Sustained efficacy and tolerability of pramipexole extended-release in early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Harjula, J.
    Sohr, M.
    Salin, L.
    Shapira, A. H. V.
    MOVEMENT DISORDERS, 2010, 25 (07) : S306 - S306
  • [10] Conversion from sustained release carbidopa/levodopa to Stalevo® in Parkinson's disease patients
    Pahwa, R
    Lyons, KE
    MOVEMENT DISORDERS, 2005, 20 : S71 - S71
12345